BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16626695)

  • 1. Importance of ryanodine receptors in effects of cyclic GMP is reduced in thyroxine-induced cardiac hypertrophy.
    Zhang Q; Goel N; Rodriguez R; Scholz PM; Weiss HR
    Eur J Pharmacol; 2006 May; 537(1-3):45-51. PubMed ID: 16626695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cyclic GMP and its protein kinase on the contraction of ventricular myocytes from hearts after cardiopulmonary arrest.
    Su J; Scholz PM; Tse J; Weiss HR
    Can J Physiol Pharmacol; 2004 Nov; 82(11):986-92. PubMed ID: 15644938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic GMP signaling and regulation of SERCA activity during cardiac myocyte contraction.
    Zhang Q; Scholz PM; He Y; Tse J; Weiss HR
    Cell Calcium; 2005 Mar; 37(3):259-66. PubMed ID: 15670873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative inotropic effects of C-type natriuretic peptide are attenuated in hypertrophied ventricular myocytes associated with reduced cyclic GMP production.
    Moalem J; Davidov T; Zhang Q; Grover GJ; Weiss HR; Scholz PM
    J Surg Res; 2006 Sep; 135(1):38-44. PubMed ID: 16600302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases.
    Weiss HR; Gong GX; Straznicka M; Yan L; Tse J; Scholz PM
    Can J Physiol Pharmacol; 1999 Jun; 77(6):422-31. PubMed ID: 10537228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative functional effects of cGMP mediated by cGMP protein kinase are reduced in T4 cardiac myocytes.
    Engel S; Yan L; Weiss H; Scholz P
    Eur J Pharmacol; 2001 Jun; 421(1):23-30. PubMed ID: 11408045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative functional effects of natriuretic peptides are attenuated in hypertrophic cardiac myocytes by reduced particulate guanylyl cyclase activity.
    Meyer M; Zhang Q; Khurana K; Scholz PM; Weiss HR
    J Cardiovasc Pharmacol; 2007 Feb; 49(2):100-5. PubMed ID: 17312451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SERCA inhibition limits the functional effects of cyclic GMP in both control and hypertrophic cardiac myocytes.
    Zhang Q; Davidov T; Weiss HR; Scholz PM
    Pharmacology; 2009; 83(4):223-30. PubMed ID: 19258738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling.
    Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
    Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T4-induced cardiac hypertrophy disrupts cyclic GMP mediated responses to brain natriuretic peptide in rabbit myocardium.
    Katz E; Zhang Q; Weiss HR; Scholz PM
    Peptides; 2006 Sep; 27(9):2276-83. PubMed ID: 16762459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of phospholamban in cyclic GMP mediated signaling in cardiac myocytes.
    Zhang Q; Scholz PM; Pilzak A; Su J; Weiss HR
    Cell Physiol Biochem; 2007; 20(1-4):157-66. PubMed ID: 17595525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic effects of intrapipette cyclic guanosine monophosphate on L-type calcium current and contraction of guinea pig ventricular myocytes.
    Shirayama T; Pappano AJ
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1274-81. PubMed ID: 8968351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic GMP protein kinase activity is reduced in thyroxine-induced hypertrophic cardiac myocytes.
    Yan L; Zhang Q; Scholz PM; Weiss HR
    Clin Exp Pharmacol Physiol; 2003 Dec; 30(12):943-50. PubMed ID: 14678234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic GMP-induced reduction in cardiac myocyte function is partially mediated by activation of the sarcoplasmic reticulum Ca(2+)-ATPase.
    Zhang Q; Yan L; Weiss HR; Scholz PM
    Pharmacology; 2002 Feb; 64(2):106-12. PubMed ID: 11803251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic GMP reduces ventricular myocyte stunning after simulated ischemia-reperfusion.
    Gandhi A; Yan L; Scholz PM; Huang MW; Weiss HR
    Nitric Oxide; 1999 Dec; 3(6):473-80. PubMed ID: 10637126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced ryanodine receptor to dihydropyridine receptor ratio may underlie slowed contraction in a rabbit model of left ventricular cardiac hypertrophy.
    Milnes JT; MacLeod KT
    J Mol Cell Cardiol; 2001 Mar; 33(3):473-85. PubMed ID: 11181016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered effects of acetylcholine on cyclic AMP and GMP induced changes in O2 consumption of hypertrophic dog cardiac myocytes.
    Gong GX; Straznicka M; Weiss HR; Tse J; Scholz PM
    J Auton Pharmacol; 1999 Feb; 19(1):19-28. PubMed ID: 10385266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between the opposing functional effects of cyclic AMP and cyclic GMP in hypertrophic cardiac myocytes.
    Patel KN; Yan L; Gandhi A; Scholz PM; Weiss HR
    Basic Res Cardiol; 2001 Feb; 96(1):34-41. PubMed ID: 11215530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels.
    Fischmeister R; Castro L; Abi-Gerges A; Rochais F; Vandecasteele G
    Comp Biochem Physiol A Mol Integr Physiol; 2005 Oct; 142(2):136-43. PubMed ID: 15927494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative effect of nitric oxide on shortening-frequency relationship in cardiac myocytes is diminished after simulated ischemia-reperfusion.
    Weiss HR; Gandhi A; Scholz PM
    Basic Res Cardiol; 2003 Sep; 98(5):311-8. PubMed ID: 12955404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.